Skip to Content
Contact Form Map & Directions Videos

Congressional Hearing on Proposed FDA Rule Change

04/2/2014
Articles
BY

Yesterday afternoon, Congress’s Subcommittee on Health held a hearing to examine the FDA’s proposal to change the rules of generic drug labeling. Under the current law, enacted in 1984, warning labels for particular drug formulations are created by the brand-name manufacturers, and generic manufacturers are legally prevented from altering them. […]

Read More

CDC: Autism Rates Jump 30 Percent, Boys Most Affected

03/31/2014
Announcement
BY

When the mercury-based preservative thimerosol was slowly removed from childhood vaccines it was assumed that the astonishing rates of autism would decline. Autism is a brain abnormalty that makes children socially awkward if not totally withdrawn. For years it was suspected that mercury toxicity was behind cases of autism, estimated […]

Read More

The Penalty Game

03/31/2014
Articles
BY

Johnson and Johnson (J&J) and its subsidiary Janssen Pharmaceuticals have been dealing with multiple lawsuits stemming from its drug Risperdal. Shortly after dodging a $1.2 billion judgment in Arkansas, J&J has returned its focus to the multidistrict litigation (MDL) currently pending in Pennsylvania. The company is now trying to shield […]

Read More

When Money Influences Medicine

03/27/2014
Articles
BY

The Wall Street Journal reports on conflict of interest disclosures that have evolved as a result of transvaginal mesh (TVM) lawsuits filed against healthcare giant, Ethicon, a division of Johnson & Johnson. Amid the hundreds of thousands of pages of documents provided in the 17,000 cases filed in federal court […]

Read More

Hear What Our Clients Have To Say

"Without question, a tier one law firm! I have been extremely pleased with the quality of service and their attention to detail. Everyone has been extraordinarily kind and professional. I highly recommend this fine organization!"
Posted By: Bud Wilder